Abstract
Aims/hypothesis Ablation of gastric inhibitory polypeptide ( GIP) receptor action is reported to protect against obesity and associated metabolic abnormalities. The aim of this study was to use prediabetic ob/ob mice to examine whether 60 days of chemical GIP receptor ablation with (Pro(3)) GIP is able to counter the development of genetic obesity-related diabetes.
Original language | English |
---|---|
Pages (from-to) | 1532-1540 |
Number of pages | 9 |
Journal | Diabetologia |
Volume | 50 |
Issue number | 7 |
DOIs | |
Publication status | Published - Jul 2007 |
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Internal Medicine